Response Genetics (OTCMKTS:RGDXQ) versus Alpha Teknova (NASDAQ:TKNO) Critical Comparison

Alpha Teknova (NASDAQ:TKNO) and Response Genetics (OTCMKTS:RGDXQ) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Analyst Ratings

This is a summary of current ratings for Alpha Teknova and Response Genetics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	0	1	1	0	2.50
Response Genetics	0	0	0	0	N/A

Alpha Teknova presently has a consensus price target of $5.00, indicating a potential upside of 1.21%. Given Alpha Teknova’s higher possible upside, analysts clearly believe Alpha Teknova is more favorable than Response Genetics.

Earnings and Valuation

This table compares Alpha Teknova and Response Genetics’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$34.94 million	5.77	-$36.78 million	($1.05)	-4.70
Response Genetics	N/A	N/A	N/A	N/A	N/A

Response Genetics has lower revenue, but higher earnings than Alpha Teknova.

Institutional and Insider Ownership

13.8% of Alpha Teknova shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by company insiders. Comparatively, 4.9% of Response Genetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Alpha Teknova and Response Genetics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-98.08%	-37.00%	-25.88%
Response Genetics	N/A	N/A	N/A

Summary

Alpha Teknova beats Response Genetics on 5 of the 8 factors compared between the two stocks.

About Alpha Teknova

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

About Response Genetics

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.